510(k) K182353
K182353 is an FDA 510(k) premarket notification submitted by Phadia AB for the device "EliA CENP Immunoassay, EliA U1RNP Immunoassay, EliA RNP70 Immunoassay". The FDA issued a decision of Substantially Equivalent on November 27, 2018. The device falls under product code LJM (Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls), a Class II device regulated under 21 CFR 866.5100. Phadia AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 27, 2018
- Date Received
- August 29, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type